Neuland Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories has issued a postal ballot notice seeking shareholder approval for the appointment of Dr. Ravi Shankar Gopinath (DIN: 00803847) as an Independent Director for a five-year term from August 1, 2025 to July 31, 2030. Dr. Gopinath, aged 59, holds a PhD in Chemical Engineering from Rensselaer Polytechnic Institute and an M.Tech from IIT Bombay, with leadership experience at TCS, Geometric Ltd., Schneider Electric, and AVEVA plc (a FTSE-listed industrial software firm). He was already inducted as an Additional Director (Independent) on August 1, 2025, and the company is now seeking formal shareholder approval as required by SEBI Listing Regulations. E-voting will be open from August 28, 2025 (9:00 AM) to September 26, 2025 (5:00 PM), with results to be announced by September 28, 2025.
This is a routine governance action to formalize the addition of a technically experienced independent director. His background in digital technology, strategy, and M&A may add value to the board, but the move is unlikely to materially move the stock on its own.